Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2006

Open Access 01-12-2006 | Original investigation

The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study

Authors: Iraj Nabipour, Katayon Vahdat, Seyed Mojtaba Jafari, Raha Pazoki, Zahra Sanjdideh

Published in: Cardiovascular Diabetology | Issue 1/2006

Login to get access

Abstract

Background

The metabolic syndrome together with insulin resistance and their consequences are basic factors in pathogenesis of atherosclerosis. Chronic infections with herpes simplex virus type 1 (HSV-1), cytomegalovirus (CMV), and Chlamydia pneumoniae are associated with the development of atherosclerosis and coronary heart disease. The infectious aspects of metabolic syndrome have not been investigated.

Methods

In a cross-sectional, population-based study, we used National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP)-III criteria in 1791 subjects, aged 25 years and over, selected by cluster random sampling in three Iranian ports in the northern Persian Gulf. Sera were analyzed for IgG antibodies to Chlamydia pneumoniae, HSV-1, Helicobacter pylori (H. pylori) and CMV using ELISA.

Results

In multiple logistic regression analysis, of the infectious agents, CMV [OR = 1.81 (1.05–3.10); p = 0.03], H. pylori [OR = 1.50 (1.12–2.00); p = 0.007] and Chlamydia pneumoniae [OR = 1.69 (1.27–2.25); p < 0.0001] showed a significant association with the metabolic syndrome in men and HSV-1 [OR = 1.95 (1.22–3.11); p = 0.005], H. pylori [OR = 1.45 (1.09–1.94); 0.01] and Chlamydia pneumoniae [OR = 1.65 (1.23–2.21); p = 0.001] in women.

Conclusion

The metabolic syndrome, which occurs very frequently in the general population, has a significant association with prior infection with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus and herpes simplex virus type 1. Hypothesis about participation of infection in pathogenesis of metabolic syndrome should be investigated.
Literature
1.
go back to reference Liese AD, Mayer-Davis EJ, Haffner SM: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998, 20: 157-172.CrossRefPubMed Liese AD, Mayer-Davis EJ, Haffner SM: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998, 20: 157-172.CrossRefPubMed
2.
go back to reference Grundy S: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002, 105: 2696-2698. 10.1161/01.CIR.0000020650.86137.84.CrossRefPubMed Grundy S: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002, 105: 2696-2698. 10.1161/01.CIR.0000020650.86137.84.CrossRefPubMed
3.
go back to reference Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004, 27: 2444-2449.CrossRefPubMed Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004, 27: 2444-2449.CrossRefPubMed
4.
go back to reference Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States Adults. Circulation. 2004, 110: 1245-1250. 10.1161/01.CIR.0000140677.20606.0E.CrossRefPubMed Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States Adults. Circulation. 2004, 110: 1245-1250. 10.1161/01.CIR.0000140677.20606.0E.CrossRefPubMed
5.
go back to reference Devaraj S, Rosenson RS, Jialal I: Metabolic syndrome:an appraisal of the proinflamatory and pro-coagulant status. Endocrinol Metabol Clin N Am. 2004, 33: 431-453. 10.1016/j.ecl.2004.03.008.CrossRef Devaraj S, Rosenson RS, Jialal I: Metabolic syndrome:an appraisal of the proinflamatory and pro-coagulant status. Endocrinol Metabol Clin N Am. 2004, 33: 431-453. 10.1016/j.ecl.2004.03.008.CrossRef
6.
go back to reference Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, Psaty BM, Tracy RP, Kuller LH, Kronmal RA: Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease in older adults: The Cardiovascular Heart Study. Circulation. 2000, 102: 2335-2340.CrossRefPubMed Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, Psaty BM, Tracy RP, Kuller LH, Kronmal RA: Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease in older adults: The Cardiovascular Heart Study. Circulation. 2000, 102: 2335-2340.CrossRefPubMed
7.
go back to reference Aristo V: A look at infectious agents as a possible causative factor in cardiovascular disease. Science. 2003, 34: 6-11. Aristo V: A look at infectious agents as a possible causative factor in cardiovascular disease. Science. 2003, 34: 6-11.
8.
go back to reference Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
9.
go back to reference Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, Willeit J, Kiechl S, Wick G: Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 2000, 102: 14-20.CrossRefPubMed Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, Willeit J, Kiechl S, Wick G: Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 2000, 102: 14-20.CrossRefPubMed
10.
go back to reference Andel M, Tsevegjav A, Roubalova K, Hruba D, louhy P, Kraml P: Infectious and inflammatory factors in the etiology and pathogenesis of atherosclerosis. Vnitr lek. 2003, 94: 960-966. Andel M, Tsevegjav A, Roubalova K, Hruba D, louhy P, Kraml P: Infectious and inflammatory factors in the etiology and pathogenesis of atherosclerosis. Vnitr lek. 2003, 94: 960-966.
11.
go back to reference Vercellotti GM: Microbs, inflammation and atherosclerosis: will old pathology lessons guide new therapies?. Trans Am Clin Climatol Assoc. 2001, 112: 215-222.PubMedCentralPubMed Vercellotti GM: Microbs, inflammation and atherosclerosis: will old pathology lessons guide new therapies?. Trans Am Clin Climatol Assoc. 2001, 112: 215-222.PubMedCentralPubMed
12.
go back to reference Willerson JT, Ridker PM: Inflammation as a cardiovascular risk factor. Circulation. 2004, 109: II-2-II-10. 10.1161/01.CIR.0000129535.04194.38.CrossRef Willerson JT, Ridker PM: Inflammation as a cardiovascular risk factor. Circulation. 2004, 109: II-2-II-10. 10.1161/01.CIR.0000129535.04194.38.CrossRef
13.
go back to reference Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8 year follow up of 14719 initially healthy American women. Circulation. 2003, 107: 391-397. 10.1161/01.CIR.0000055014.62083.05.CrossRefPubMed Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8 year follow up of 14719 initially healthy American women. Circulation. 2003, 107: 391-397. 10.1161/01.CIR.0000055014.62083.05.CrossRefPubMed
14.
go back to reference Rose R: Atherosclerosis: an inflammatory disease?. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.CrossRef Rose R: Atherosclerosis: an inflammatory disease?. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.CrossRef
15.
go back to reference Danesh J, Whincup PI, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J. 2000, 321: 199-204. 10.1136/bmj.321.7255.199.CrossRef Danesh J, Whincup PI, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J. 2000, 321: 199-204. 10.1136/bmj.321.7255.199.CrossRef
16.
go back to reference Fernandez-Real JM, Wifredo R: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Review. 2003, 24: 278-301. 10.1210/er.2002-0010.CrossRef Fernandez-Real JM, Wifredo R: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Review. 2003, 24: 278-301. 10.1210/er.2002-0010.CrossRef
17.
go back to reference Fisman EZ, Motro M, Tenenbaum A: Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol. 2003, 2: 11-10.1186/1475-2840-2-11.PubMedCentralCrossRefPubMed Fisman EZ, Motro M, Tenenbaum A: Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol. 2003, 2: 11-10.1186/1475-2840-2-11.PubMedCentralCrossRefPubMed
18.
19.
go back to reference Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE: Tumor necrosis factor-alpha mediated insulin resistance, but not dedifferentiation, is abrogated by MEKl/2 inhibitors in 3T3-L1 adipocytes. Mol Endo. 2000, 14: 1557-1569. 10.1210/me.14.10.1557. Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE: Tumor necrosis factor-alpha mediated insulin resistance, but not dedifferentiation, is abrogated by MEKl/2 inhibitors in 3T3-L1 adipocytes. Mol Endo. 2000, 14: 1557-1569. 10.1210/me.14.10.1557.
20.
go back to reference Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 1994, 3: 1271-1278.CrossRef Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 1994, 3: 1271-1278.CrossRef
21.
go back to reference Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC: Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990, 12: 1179-1186.CrossRefPubMed Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC: Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990, 12: 1179-1186.CrossRefPubMed
22.
go back to reference Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance. Diabetologia. 2003, 46: 1594-603. 10.1007/s00125-003-1228-z.CrossRefPubMed Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance. Diabetologia. 2003, 46: 1594-603. 10.1007/s00125-003-1228-z.CrossRefPubMed
23.
go back to reference Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome. Diabetologia. 1997, 40: 1286-1292. 10.1007/s001250050822.CrossRefPubMed Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome. Diabetologia. 1997, 40: 1286-1292. 10.1007/s001250050822.CrossRefPubMed
Metadata
Title
The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study
Authors
Iraj Nabipour
Katayon Vahdat
Seyed Mojtaba Jafari
Raha Pazoki
Zahra Sanjdideh
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2006
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-5-25

Other articles of this Issue 1/2006

Cardiovascular Diabetology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.